Skip to content
  • Saturday, 16 May 2026
  • 5:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Arrowhead Pharmaceuticals Secures Australian TGA Approval for Redemplo, Offering Hope for Familial Chylomicronemia Syndrome Patients
Pharmaceutical R&D

Arrowhead Pharmaceuticals Secures Australian TGA Approval for Redemplo, Offering Hope for Familial Chylomicronemia Syndrome Patients

Teuku Ryan May 4, 2026 0

The Australian Therapeutic Goods Administration (TGA) has granted approval for Arrowhead Pharmaceuticals’ Redemplo (plozasiran), a novel therapeutic agent designed to…

Read More
Quintessence Biotech Unveils Groundbreaking Artificial Cell Technology to Revolutionize Cell and Gene Therapy ManufacturingCity skylines influence cloud formation above themTWiV 1289: Building a Better Hepatitis B TrapHow Clinical Laboratories Can Prepare for Crisis Events Before They Happen
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
To understand black holes, physicists turn to a mathematical ‘Rosetta stone’Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal HematopoiesisScientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global ResurgencePharmaceutical Industry Navigates Sustainability Paradox as Emissions Continue to Climb
YOU MAY HAVE MISSED
Environmental & Analytical Chemistry
To understand black holes, physicists turn to a mathematical ‘Rosetta stone’
Abdurrohim Arsyad May 16, 2026
Stem Cell & Regenerative Medicine
Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis
Dwi Wanna May 16, 2026
Biotech & Genetic Research
Scientists Pioneer World’s First Human Antibody Treatment for Measles, Offering Critical Defense Amid Global Resurgence
Jia Lissa May 16, 2026
Laboratory Automation & Robotics
Pharmaceutical Industry Navigates Sustainability Paradox as Emissions Continue to Climb
Lana Keisha May 16, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ